It was first isolated and characterised by Professor Predrag Sikiric and his research group at the University of Zagreb in the early 1990s, with the foundational paper published in the Journal of Physiology (Paris) in 1993
The global semaglutide markets rapid growth is driven by the increasing prevalence of type 2 diabetes and obesity, rising demand for GLP-1 receptor agonists, and growing adoption of weight-management therapies
Ki67 + cell area (m 2 ) with respect to DAPI area (/m 2 ) was evaluated using ZEN Imaging Software (Blue edition
Katherine H
Pharmacol Ther 113(3):546593 Dozio E, Vianello E, Malavazos AE, Tacchini L, Schmitz G, Iacobellis G et al (2019) Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk
This large population-based cohort of US adults with diabetes provided solid real-world evidence for incident AF events associated with GLP-1RA compared with other therapies (DPP4i, SGLT2i, and other non-insulin glucose-lowering agents other than SGLT2i)